Waters Corporation to Present at the Jefferies Global Healthcare Conference
Rhea-AI Summary
Waters (NYSE:WAT) announced that President and CEO Udit Batra, Ph.D., will join a fireside chat at the Jefferies Global Healthcare Conference on June 3, 2026, at 10:30 AM ET.
A live webcast and 90-day replay will be available on Waters' investor relations site.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Positive
- None.
Negative
- None.
News Market Reaction – WAT
On the day this news was published, WAT gained 1.16%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| May 05 | Earnings results | Positive | +13.5% | Q1 2026 beat guidance and guidance raised, lifting shares sharply. |
| Apr 20 | Earnings call setup | Neutral | -0.1% | Scheduled Q1 2026 earnings call and webcast details for investors. |
| Apr 14 | Product launch | Positive | +1.9% | Introduced omniDAWN MALS detector with faster runs and lower sample use. |
| Apr 08 | FDA clearance | Positive | +3.6% | FDA cleared at‑home Onclarity HPV kit and approved HPV assay. |
| Mar 18 | Debt offering | Negative | -0.7% | Priced $3.5B senior notes for refinancing, increasing leverage modestly. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news with clear fundamental positives (earnings beat, FDA clearance, product launch) generally coincided with positive price reactions, while balance sheet–related financing saw a modest decline.
Over recent months, Waters has reported strong Q1 2026 results with revenue of $1.267 billion and raised full‑year guidance, which was followed by a 13.54% gain after the earnings release on May 5, 2026. Earlier, FDA clearance of an at‑home HPV self‑collection kit and launch of an extended‑range MALS detector also saw positive reactions. A March $3.5 billion senior notes offering led to a smaller -0.65% move, highlighting sensitivity to added leverage versus growth news. Today’s conference appearance fits into ongoing investor outreach rather than a new fundamental catalyst.
AI-generated analysis. How Rhea-AI works. Not financial advice.
A live webcast of the event will be available on the 'Events & Presentations' section of Waters Investor Relations website at https://ir.waters.com. A replay of the webcast will be available for 90 days.
About Waters Corporation
Waters Corporation (NYSE:WAT) is a global leader in life sciences, dedicated to accelerating the benefits of pioneering science through analytical technologies, informatics, and service. With a focus on regulated, high-volume testing environments, our innovative portfolio harnesses deep scientific expertise across chemistry, physics, and biology. We collaborate with analytical laboratories around the world to advance the release of effective, high-quality medicines, assure the safety of food and water, and drive better patient outcomes by detecting diseases earlier, managing routine infections, and combatting growing antibiotic resistance. Through a shared culture of relentless innovation, our passionate team of approximately 16,000 employees partner with our customers to turn scientific challenges into breakthroughs that improve lives worldwide.
Caspar Tudor, Head of Investor Relations
investor_relations@waters.com
View original content:https://www.prnewswire.com/news-releases/waters-corporation-to-present-at-the-jefferies-global-healthcare-conference-302775033.html
SOURCE Waters Corporation